Abstract
Cryptophycin 1 is a natural product that was initially isolated from blue-green algae which has shown potent broad spectrum antitumor activity in preclinical in vitro and in vivo models. The drug strongly binds to tubulin and disrupts microtubule assembly for more than 24 hours after its removal. We evaluated cell survival, intracellular levels and inhibition of macromolecular synthesis in L1210 cells following exposure to cryptophycin 1 in vitro. Cell survival was strongly inhibited following drug exposure for either 1 or 4 hours. Intracellular drug levels were minimally affected by temperature (4°C versus 37°C) or exposure times up to 1 hour. However, extracellular drug concentration in culture media and increasing cell numbers did affect the concentration of intracellular drug levels in a nearly proportional manner. The synthesis of DNA and RNA was inhibited less than 5%, while protein synthesis inhibition was near 30%. Thus, none of the macromolecules were inhibited enough to explain the inhibition of tumor cell growth.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Cragg GM, Newman DJ, Snader KM: Natural products in drug discovery and development. J Nat Prod 60: 52-60, 1997
Stewart CF, Ratain MJ: Topoisomerase interactive agents. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: Principles and Practice of Oncology. 5th Edn. Lippincott-Raven, Philadelphia, 1997, pp 452-467
Rowinsky EK, Donehower RC: Antimicrotubule agents. In: DeVita VT, Hellman S, Rosenberg SA (eds) Cancer: Principles and Practice of Oncology. 5th Edn. Lippincott-Raven, Philadelphia, 1997, pp 467-483
Schwartz RE, Hirsch CF, Sesin DF, Flor JE, Chartrain M, Fromtling RE, Harris GH, Salvatore MJ, Liesch JM, Yudin K: Pharmaceuticals from cultured algae. J Indust Microbiol 5: 113-124, 1990
Golakoti T, Ohtani I, Patterson GML, Moore RE, Corbett TH, Valeriote FA, Demchick L: Total structures of cryptophycins, potent antitumor depsipeptides from blue-green algae Nostacsp. strain GSV224. J Am Chem Soc 116: 4729-4737, 1994
Smith CD, Zhang X, Mooberry SL, Patterson GML, Moore RE: Cryptophycin: a new antimicrotubule agent active against drug-resistant cells. Cancer Res 54: 3779-3784, 1994
Moore RE, Corbett TH, Patterson GML, Valeriote FA: The search for new antitumor drugs from blue-green algae. Curr Pharmaceut Des 2: 317-330, 1996
Corbett TH, Valeriote FA, Demchick L, Lowichik N, Polin L, Panchapor C, Pugh S, White K, Kushner J, Rake J, Wentland M, Golakoti T, Hetzel C, Ogino J, Patterson G, Moore R: Discovery of cryptophycin 1 and BCN-183577: examples of strategies and problems in the detection of antitumor activity in mice. Invest New Drugs 15: 207-218, 1997
Bai R, Schwartz RE, Kepler JA, Pettit GR, Hamel E: Characterization of the interaction of cryptophycin 1 with tubulin: binding in the Vincadomain competitive inhibition of dolostatin 10 binding, and an unusual aggregation reaction. Cancer Res 56: 4398-4406, 1996
Smith CD, Zhang X: Mechanism of action cryptophycin. Interaction with the vinca alkaloid domain of tubulin. J Biol Chemistry 271: 6192-6198, 1996
Corbett TH, Valeriote FA, Polin L, Panchapor C, Pugh S, White K, Lowichik N, Knight J, Bissery MC, Wozniak A, LoRusso P, Biernat L, Polin D, Knight L, Piggar S, Looney D, Demchick L, Jones J, Blain S, Palner K, Essenmaker S, Lisow L, Mattes KC, Cavannaugh PF, Rake JB, Baker L: Discovery of solid tumor active agents using a soft-agar colony-formation disk-diffusion assay. In: Valeriote FA, Corbett TH, Baker LH (eds) Cytotoxic Anticancer Drugs: Models and Concepts for Drugs Discovery and Development. Kluwer Academic Publishers, Boston, 1990, pp 33-87
LoRusso P, Foster BJ, Poplin E, McCormick J, Kraut M, Flaherty L, Heilbrun L, Valdivieso M, Baker L: Phase I clinical trial of pyrazoloacridine NSC 366140 (PD 115934). Clin Cancer Res 1: 1487-1493, 1995
Foster BJ, Jones L, Wiegand R, LoRusso PM, Corbett TH: Preclinical pharmacokinetic, antitumor and toxicity studies with CI-994 (N-acetyldinaline). Invest New Drugs 15: 187- 194, 1997
Foster BJ, Wiegand RA, Pugh S, LoRusso PM, Rake J, Corbett TH: Pharmacokinetic studies in mice of two new thioxanthenones (183577 and 232759) that showed preferential solid tumor activity. Clin Cancer Res 3: 2047-2053, 1997
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Foster, B.J., Fortuna, M., Media, J. et al. Cryptophycin 1 cellular levels and effects in vitro using L1210 cells. Invest New Drugs 16, 199–204 (1998). https://doi.org/10.1023/A:1006148127527
Issue Date:
DOI: https://doi.org/10.1023/A:1006148127527